Results 71 to 80 of about 395,313 (278)

Antibacterial Micro/Nanorobots: Innovations, Challenges, and Future Perspectives in Combatting Infection

Nano Select, EarlyView.
Antibacterial micro/nanorobots (MNRs) represent a breakthrough in antibacterial therapy, making precise delivery of drugs to the infection site. This review systematically summarizes the material composition, actuation, and applications of MNRs in combating biofilms and drug‐resistant infections while emphasizing the existing challenges of ...
Yichao Chen, Chenlin Jiang, Chuxie Zhang, Wenqing He, Changshun Hou   +4 more
wiley   +1 more source

Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling

Bioscience Reports, 2019
Morusin has been traditionally used for the treatment of Mycoplasma pneumoniae pneumonia (MPP), but the underlying mechanism remains elusive. The present study aimed to explore the mechanism by which morusin achieves efficacy on mycoplasma pneumonia ...
Cunrong Chen, Jingjing Wang, Jianfei Chen, Lili Zhou, Hui Wang, Junnian Chen, Zhihui Xu, S. Zhu, Wei Liu, R. Yu, Junli Lu, Haoteng Luo, Min Chen, Weiwen Chen   +13 more
semanticscholar   +1 more source

Interaction analysis of non‐bacterial respiratory pathogens during and after the coronavirus disease 2019 pandemic in two cities along the eastern coast of China

Pediatric Investigation, EarlyView.
What is Known • Co‐infections can influence pathogen replication, disease severity, and the duration of illness. • Co‐infection patterns and temporal correlations have been characterized among various respiratory viruses and atypical pathogens. What is New • A consistent negative correlation between influenza B and Mycoplasma pneumoniae suggests ...
Wanxian Ye, Jishan Zheng, Yungang Yang, Xinyue Song, Xiang Yuan, Lan Yang, Jian Yu, Hailin Zhang, Shunhang Wen   +8 more
wiley   +1 more source

Mycoplasma pneumonia with hydropneumothorax: A case report

Respiratory Medicine Case Reports, 2019
Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia in adults. Mycoplasma pneumoniae pneumonia (MPP) presents with pulmonary and extrapulmonary manifestations. Pneumothorax is a rare MPP complication in children.
Ateeq Mubarik, Aamani Jupalli, Arshad Muhammad Iqbal, Sohaib Khaleel Mohammed, Salman Muddassir, Eddib Abdulmagid   +5 more
doaj   +1 more source

Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children

Pakistan Journal of Medical Sciences, 2019
Objective: To study and compare the clinical effects of azithromycin and erythromycin on children with mycoplasma pneumonia. Methods: Total 132 children with mycoplasma pneumonia who were admitted to our hospital between November 2017 and September 2018 ...
Rui Han, Qia-chao Yu, Guohui Zhang, Baoqiang Li, Shu-zhen Han, Guiying Li   +5 more
semanticscholar   +1 more source

Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population‐Based Registry Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies. Design Population‐based cohort study. Setting Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry ...
Thomas Boissiere‐O'Neill, Marleen M. H. J. van Gelder, Hilde M. Engjom, Hedvig M. E. Nordeng   +3 more
wiley   +1 more source

A 3D-Printed Microfluidic Device for qPCR Detection of Macrolide-Resistant Mutations of Mycoplasma pneumoniae

Biosensors, 2021
Mycoplasma pneumonia (MP) is a common respiratory infection generally treated with macrolides, but resistance mutations against macrolides are often detected in mycoplasma pneumoniae in China.
Anyan Wang, Zhenhua Wu, Yuhang Huang, Hongbo Zhou, Lei Wu, Chunping Jia, Qiang Chen, Jianlong Zhao   +7 more
doaj   +1 more source

Mycoplasma pneumoniaepneumonia in children

Korean Journal of Pediatrics, 2012
Mycoplasma pneumoniae (MP), the smallest self-replicating biological system, is a common cause of upper and lower respiratory tract infections, leading to a wide range of pulmonary and extra-pulmonary manifestations. MP pneumonia has been reported in 10 to 40% of cases of community-acquired pneumonia and shows an even higher proportion during epidemics.
Youn, You-Sook, Lee, Kyung-Yil
openaire   +2 more sources

Single‐dose Pasteurella multocida and Histophilus somni autogenous vaccines administered at induction significantly improved feedlot cattle performance and profitability in Australia

Australian Veterinary Journal, EarlyView.
Background Bovine respiratory disease (BRD) is the most economically important disease affecting feedlot cattle. While viral pathogens are initiating agents, bacterial coinfections exacerbate disease severity. Vaccines for Pasteurella multocida and Histophilus somni are not commercially available in Australia.
GM Werid, T Batterham, L O'Meara, K Petrovski, WS Pitchford, DJ Trott   +5 more
wiley   +1 more source

Mycoplasma pneumoniae‐Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Mycoplasma pneumoniae‐induced rash and mucositis (MIRM) is a mucocutaneous eruption affecting children and young adults with respiratory tract or clinically occult infection by M. pneumoniae. Mucosal involvement is often robust and may raise concern for Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
Margaret Lang Houser, Jennifer B. Mancuso, Johann E. Gudjonsson, Alexandra C. Hristov, Lori Lowe, May P. Chan   +5 more
wiley   +1 more source